# Bovine Sacroiliac Ligament **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bovine-sacroiliac-ligament **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-28 **Evidence Score:** 2 / 10 **Category:** Protein **Also Known As:** Bovine SI ligament, Cattle sacroiliac ligament, BSL (bovine sacroiliac ligament), Bovine dorsal sacroiliac ligament, Bos taurus sacroiliac ligament ## Overview Bovine sacroiliac ligament is a dense connective tissue harvested from cattle, rich in type I collagen fibrils (~40 Å microfibrils), proteoglycans, and glycosaminoglycans such as decorin and biglycan. Research has focused almost entirely on decellularized extracellular matrix (dECM) scaffolds for preclinical tissue engineering rather than oral supplementation or documented human health benefits. ## Health Benefits • No documented health benefits - exclusively studied for biomedical engineering applications (preclinical evidence only) • Potential scaffold material for tissue engineering - retains native ECM structure when decellularized (in vitro studies) • Rich in collagen fibrils (~40 Å microfibrils) - theoretical structural protein source (laboratory characterization only) • Contains proteoglycans similar to other connective tissues - no therapeutic effects established (compositional analysis only) • Mechanical properties studied for biomaterial applications - no supplementation benefits demonstrated (engineering research only) ## Mechanism of Action Bovine sacroiliac ligament tissue is densely organized around type I collagen fibrils cross-linked via lysyl oxidase-mediated pyridinoline bonds, which provide tensile load-bearing capacity. The resident proteoglycans—primarily decorin and biglycan—bind TGF-β, modulating fibroblast activity and collagen fibril diameter regulation through the leucine-rich repeat domain interaction. When processed as a decellularized scaffold, retained fibronectin, laminin, and heparan sulfate proteoglycans support cell adhesion via integrin α5β1 and αvβ3 signaling, promoting fibroblast and chondrocyte proliferation in vitro. ## Clinical Summary No human clinical trials have been conducted using bovine sacroiliac ligament as an oral supplement or injectable therapy. Preclinical in vitro studies have demonstrated that decellularized sacroiliac ligament scaffolds retain native ECM architecture with approximately 40 Å collagen microfibrils and support seeded fibroblast viability. Animal model research (rodent and ovine, n typically under 30 per study) has explored these scaffolds for ligament repair, showing partial restoration of tensile strength compared to native tissue controls. The overall evidence base is exclusively preclinical and biomedical-engineering-focused, making any claims about human health benefits from supplementation entirely unsupported. ## Nutritional Profile Bovine Sacroiliac Ligament is a dense connective tissue composed predominantly of Type I collagen (~70-80% of dry weight), with smaller fractions of Type III and Type V collagen. Protein content is high (~60-70% wet weight basis estimated from analogous dense ligament tissue). Collagen microfibrils are organized at ~40 Å periodicity with characteristic D-banding. Non-collagenous protein fraction includes proteoglycans (decorin, biglycan, aggrecan in minor quantities) and glycoproteins (fibronectin, tenascin). Glycosaminoglycan (GAG) content estimated at 5-15 mg/g dry weight based on comparable bovine ligament tissue data, primarily dermatan sulfate and chondroitin sulfate. Fat content is minimal (<5% dry weight), primarily structural phospholipids within residual cellular membranes. Moisture content of fresh tissue approximately 60-70%. Mineral content includes calcium (~2-5 mg/g dry weight) and phosphorus in hydroxyapatite-associated fractions near enthesis zones. Zinc, copper, and manganese present at trace levels (<1 mg/g) as metalloprotein cofactors. Hydroxyproline content ~13-14% of total amino acids, consistent with collagen-rich tissues. Glycine (~33%), proline (~12%), and alanine (~11%) constitute dominant amino acid profile. Bioavailability of intact collagen is low when consumed whole; hydrolyzed collagen peptides derived from similar tissue sources show ~90% intestinal absorption in human studies, but specific bioavailability data for sacroiliac ligament-derived protein is absent from nutritional literature. No vitamins documented in appreciable quantities. ## Dosage & Preparation No clinically studied dosage ranges exist as this ingredient has not been tested in human trials. Current research only describes lyophilized acellular fibers for scaffold applications with no standardization for supplementation. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions No human safety data, established dosing ranges, or toxicology profiles exist for bovine sacroiliac ligament consumed as a dietary supplement. As a bovine-derived tissue product, it carries a theoretical risk of prion transmission (bovine spongiform encephalopathy), though regulatory sourcing controls in certified herds mitigate this risk substantially. Individuals with beef or collagen protein allergies should avoid this ingredient entirely, and it should not be used during pregnancy due to the complete absence of gestational safety data. No drug interactions have been studied; however, the proteoglycan content, particularly heparan sulfate, could theoretically potentiate anticoagulant medications such as warfarin if absorbed systemically, though oral bioavailability of intact proteoglycans remains unestablished. ## Scientific Research No human clinical trials, RCTs, or meta-analyses exist for bovine sacroiliac ligament as a supplement. Research is limited to preclinical mechanical property studies and in vitro tissue engineering applications, with no reported human outcomes or clinical use documentation. ## Historical & Cultural Context No evidence of traditional medicinal use in any systems including TCM or Ayurveda was found. All references are exclusively from modern scientific literature focusing on biomechanical and bioengineering properties. ## Synergistic Combinations Not applicable - no supplementation evidence exists ## Frequently Asked Questions ### What is bovine sacroiliac ligament used for in supplements? Bovine sacroiliac ligament has not been established as an effective oral supplement ingredient. Its documented use is confined to biomedical engineering research, where its decellularized extracellular matrix—rich in type I collagen, decorin, and biglycan—is studied as a scaffold material for ligament tissue repair in preclinical models. ### Does bovine sacroiliac ligament contain collagen? Yes, bovine sacroiliac ligament is predominantly composed of type I collagen organized into ~40 Å diameter microfibrils with pyridinoline cross-links that provide high tensile strength. It also contains smaller amounts of type III and type V collagen, along with proteoglycans like decorin that regulate fibril diameter and spacing. ### Is bovine sacroiliac ligament safe to consume? No human safety studies have been conducted on bovine sacroiliac ligament as a dietary ingredient, so no established safe dosage exists. Individuals with beef allergies or autoimmune connective tissue disorders should avoid it, and its bovine origin requires sourcing from BSE-certified herds to minimize prion disease risk. ### How is bovine sacroiliac ligament different from collagen supplements? Standard collagen supplements are hydrolyzed into di- and tripeptides (e.g., Pro-Hyp, Hyp-Gly) for high oral bioavailability, with clinical evidence supporting skin elasticity and joint comfort at 2.5–10 g daily doses. Bovine sacroiliac ligament, by contrast, has not been hydrolyzed for supplemental use and retains complex native ECM proteins including proteoglycans, with no human bioavailability data established. ### Are there any human studies on bovine sacroiliac ligament? As of current literature, there are no published human clinical trials evaluating bovine sacroiliac ligament for any health outcome. All existing research involves in vitro cell culture studies or small animal models (rodent and ovine) investigating its decellularized scaffold properties for ligament reconstruction, not its use as a consumed supplement. ### What does the research quality show about bovine sacroiliac ligament supplements? Currently, bovine sacroiliac ligament has only preclinical evidence from laboratory and in vitro studies—no human clinical trials have been published. Research to date has focused exclusively on its potential as a tissue engineering scaffold material in biomedical applications, not as a dietary supplement. This means efficacy and safety claims for oral supplementation lack the human study support typically expected for supplement ingredients. ### Who should avoid bovine sacroiliac ligament supplements? Due to the complete absence of human safety data, bovine sacroiliac ligament supplements should be avoided by pregnant and nursing women, children, and individuals with known sensitivities to beef-derived products. People with inflammatory bowel conditions or compromised immune systems should consult a healthcare provider before use, as no safety profile has been established in these populations. Additionally, those following strict vegan or vegetarian diets should note this is an animal-derived supplement. ### What is the difference between bovine sacroiliac ligament and general collagen supplements? While bovine sacroiliac ligament does contain collagen microfibrils and proteoglycans naturally present in the native tissue structure, standard collagen supplements typically contain hydrolyzed or isolated collagen peptides designed for absorption. Sacroiliac ligament is a whole tissue product that retains the extracellular matrix architecture, whereas collagen supplements are processed into smaller, more bioavailable fragments—a key distinction given that sacroiliac ligament lacks any absorption or bioavailability studies in humans. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*